Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,627
Closed -$184K 200
2022
Q1
$184K Sell
2,627
-2
-0.1% -$135 0.02% 162
2021
Q4
$164K Sell
2,629
-38,795
-94% -$2.43M 0.02% 165
2021
Q3
$2.56M Buy
41,424
+3,768
+10% +$227K 0.33% 39
2021
Q2
$2.25M Sell
37,656
-2,425
-6% -$154K 0.27% 42
2021
Q1
$2.44M Buy
40,081
+4,431
+12% +$245K 0.29% 42
2020
Q4
$1.67M Buy
+35,650
New +$1.54M 0.22% 40
2020
Q3
Sell
-4,825
Closed -$176K 218
2020
Q2
$176K Sell
4,825
-132
-3% -$4.59K 0.04% 65
2020
Q1
$152K Sell
4,957
-2,694
-35% -$119K 0.06% 66
2019
Q4
$390K Buy
7,651
+1,894
+33% +$91.4K 0.14% 51
2019
Q3
$272K Buy
5,757
+521
+10% +$24.8K 0.03% 52
2019
Q2
$260K Hold
5,236
0.02% 46
2019
Q1
$223K Buy
5,236
+1,564
+43% +$69.2K 0.12% 39
2018
Q4
$151K Buy
+3,672
New +$158K 0.07% 47

Other funds holding MET

Mirova's MET Position: Q2 2022 in Review

Mirova sold out of MetLife (MET) in Q2 2022, closing a stake of 2,627 shares — an estimated $184K sold.

Mirova first reported a position in MET in Q4 2018 and held it in 13 quarters. The position peaked at $2.56M in Q3 2021. 1,198 funds tracked by Wall St. Rank hold MET as of Q2 2022.

  • Mirova reported no remaining MetLife position as of Q2 2022 after selling out during the quarter.
  • Mirova sold 2,627 MetLife shares in Q2 2022, an estimated $184K.
  • Mirova first reported a position in MetLife in Q4 2018 and held it in 13 quarters.
  • Mirova's MetLife position peaked at $2.56M in Q3 2021.
  • 1,198 funds tracked by Wall St. Rank held MetLife as of Q2 2022.

Based on Mirova's 13F filing for Q2 2022, filed 12 Aug 2022.